Cited by 239Pancreatic function and diabetesNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

γ-Aminobutyric Acid (GABA) Is an Autocrine Excitatory Transmitter in Human Pancreatic β-Cells

Open access
Braun, Matthias, Ramracheya, Reshma, Bengtsson, Martin, Clark, Anne, Walker, Jonathan N., Johnson, Paul R., Rorsman, Patrik·2010·Diabetes

Abstract

OBJECTIVE: Paracrine signaling via γ-aminobutyric acid (GABA) and GABAA receptors (GABAARs) has been documented in rodent islets. Here we have studied the importance of GABAergic signaling in human pancreatic islets. RESEARCH DESIGN AND METHODS: Expression of GABAARs in islet cells was investigated by quantitative PCR, immunohistochemistry, and patch-clamp experiments. Hormone release was measured from intact islets. GABA release was monitored by whole-cell patch-clamp measurements after adenoviral expression of α1β1 GABAAR subunits. The subcellular localization of GABA was explored by electron microscopy. The effects of GABA on electrical activity were determined by perforated patch whole-cell recordings. RESULTS: PCR analysis detected relatively high levels of the mRNAs encoding GABAAR α2, β3, γ2, and π subunits in human islets. Patch-clamp experiments revealed expression of GABAAR Cl− channels in 52% of β-cells (current density 9 pA/pF), 91% of δ-cells (current density 148 pA/pF), and 6% of α-cells (current density 2 pA/pF). Expression of GABAAR subunits in islet cells was confirmed by immunohistochemistry. β-Cells secreted GABA both by glucose-dependent exocytosis of insulin-containing granules and by a glucose-independent mechanism. The GABAAR antagonist SR95531 inhibited insulin secretion elicited by 6 mmol/l glucose. Application of GABA depolarized β-cells and stimulated action potential firing in β-cells exposed to glucose. CONCLUSIONS: Signaling via GABA and GABAAR constitutes an autocrine positive feedback loop in human β-cells. The presence of GABAAR in non–β-cells suggests that GABA may also be involved in the regulation of somatostatin and glucagon secretion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db09-0797

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In human islets, insulin secretion is triggered at glucose concentrations as low as 3 mM whereas 6 mM is required in mouse islets.

    “In human islets, insulin secretion is triggered at glucose concentrations as low as 3 mM whereas 6 mM is required in mouse islets (89).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [89]

    The Results section (“Effect of GABAAR blockade on insulin secretion”; page not available) reports that 3 mmol/l glucose stimulated insulin secretion in intact human islets compared with 1 mmol/l. Our copy does not establish that mouse islets require 6 mmol/l glucose to trigger insulin secretion, so the mouse comparison is unsupported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The membrane potential during interspike intervals in human β-cells may be as negative as -60 mV at 6 mM glucose, but is between -50 and -40 mV at 10 mM glucose or above.

    “This may be seen from the fact that the membrane potential during the interspike intervals may be as negative as -60 mV at 6 mM glucose, (89), but is between -50 and -40 mV at 10 mM glucose or above (52) (Figure 6 and schematic in Figure 13C-D).”

    From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [89]

    The Results section reports that human β-cells at 6 mmol/l glucose had a membrane potential of −64 ± 7 mV before GABA application, supporting the approximate −60 mV value attributed to this source. However, the reported measurement was not identified as an interspike-interval potential; the paper describes the cell in Figure 7A as electrically inactive. The 10 mmol/l-or-above comparison is attached to a different citation in the citing sentence. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • In human islets, insulin secretion is detectable at glucose concentrations as low as 3 mM, significantly lower than the secretion threshold in mouse islets (~5 mM).

    “In human islets, insulin secretion is detectable at glucose concentrations as low as 3 mM (89, 150, 266), which is significantly lower than the secretion threshold in mouse islets (~5 mM (257)).”
  • Amino acids, neurotransmitters and hormones can stimulate electrical activity and insulin release in human β-cells only in the presence of a permissive concentration of glucose.

    “Amino acids (arginine and glycine)(744), neurotransmitters (like adenine nucleotides, GABA and acetylcholine) (89, 92, 347, 568) and hormones (618) can also stimulate electrical activity and insulin release but only in the presence of a ‘permissive’ concentration of glucose.”
  • The Cl- equilibrium potential in β-cells is around -35 mV.

    “Because pancreatic β-cells have a high intracellular Cl- concentration (89), an increased Cl- conductance will depolarise the β-cells towards the Cl- equilibrium potential (ECl), which is around -35 mV (89).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 40 · Cited by 239

Research works printed but not linked: 36

  1. [1]Samols E Bonner-Weir S Weir GC: Intra-islet insulin-glucagon-somatostatin relationships. Clin Endocrinol Metab 1986; 15: 33– 58 2869846
  2. [2]Grapengiesser E Salehi A Qader SS Hellman B: Glucose induces glucagon release pulses antisynchronous with insulin and sensitive to purinoceptor inhibition. Endocrinology 2006; 147: 3472– 3477 16614082
  3. [3]Hayashi M Yamada H Uehara S Morimoto R Muroyama A Yatsushiro S Takeda J Yamamoto A Moriyama Y: Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans. J Biol Chem 2003; 278: 1966– 1974 12414805
  4. [4]Ishihara H Maechler P Gjinovci A Herrera PL Wollheim CB: Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat Cell Biol 2003; 5: 330– 335 12640462
  5. [5]Rorsman P Berggren PO Bokvist K Ericson H Möhler H Ostenson CG Smith PA: Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels. Nature 1989; 341: 233– 236 2550826
  6. [6]Bailey SJ Ravier MA Rutter GA: Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells. Diabetes 2007; 56: 320– 327 17259375
  7. [7]Wendt A Birnir B Buschard K Gromada J Salehi A Sewing S Rorsman P Braun M: Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. Diabetes 2004; 53: 1038– 1045 15047619
  8. [8]Xu E Kumar M Zhang Y Ju W Obata T Zhang N Liu S Wendt A Deng S Ebina Y Wheeler MB Braun M Wang Q: Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system. Cell Metab 2006; 3: 47– 58 16399504
  9. [10]Cabrera O Berman DM Kenyon NS Ricordi C Berggren PO Caicedo A: The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc Natl Acad Sci U S A 2006; 103: 2334– 2339 16461897 PMC1413730
  10. [11]Taniguchi H Okada Y Seguchi H Shimada C Seki M Tsutou A Baba S: High concentration of gamma-aminobutyric acid in pancreatic beta cells. Diabetes 1979; 28: 629– 633 221297
  11. [12]Wang C Ling Z Pipeleers D: Comparison of cellular and medium insulin and GABA content as markers for living beta-cells. Am J Physiol Endocrinol Metab 2005; 288: E307– E313 15454397
  12. [13]Yang W Reyes AA Lan NC: Identification of the GABAA receptor subtype mRNA in human pancreatic tissue. FEBS Lett 1994; 346: 257– 262 7516897
  13. [14]Lake SP Bassett PD Larkins A Revell J Walczak K Chamberlain J Rumford GM London NJ Veitch PS Bell PR: Large-scale purification of human islets utilizing discontinuous albumin gradient on IBM 2991 cell separator. Diabetes 1989; 38(Suppl. 1): 143– 145 2642839
  14. [15]Ricordi C Lacy PE Finke EH Olack BJ Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413– 420 3288530
  15. [16]Lernmark A: The preparation of, and studies on, free cell suspensions from mouse pancreatic islets. Diabetologia 1974; 10: 431– 438 4375640
  16. [18]Braun M Ramracheya R Amisten S Bengtsson M Moritoh Y Zhang Q Johnson PR Rorsman P: Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 2009; 52: 1566– 1578 19440689
  17. [20]Zhang Q Bengtsson M Partridge C Salehi A Braun M Cox R Eliasson L Johnson PR Renström E Schneider T Berggren PO Göpel S Ashcroft FM Rorsman P: R-type Ca(2+)-channel-evoked CICR regulates glucose-induced somatostatin secretion. Nat Cell Biol 2007; 9: 453– 460 17369816
  18. [21]Angelotti TP Macdonald RL: Assembly of GABAA receptor subunits: alpha 1 beta 1 and alpha 1 beta 1 gamma 2S subunits produce unique ion channels with dissimilar single-channel properties. J Neurosci 1993; 13: 1429– 1440 7681870 PMC6576715
  19. [22]Reetz A Solimena M Matteoli M Folli F Takei K De Camilli P: GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J 1991; 10: 1275– 1284 2022191 PMC452782
  20. [23]Braun M Wendt A Karanauskaite J Galvanovskis J Clark A MacDonald PE Rorsman P: Corelease and differential exit via the fusion pore of GABA, serotonin, and ATP from LDCV in rat pancreatic beta cells. J Gen Physiol 2007; 129: 221– 231 17296927 PMC2151613
  21. [24]Aspinwall CA Huang L Lakey JR Kennedy RT: Comparison of amperometric methods for detection of exocytosis from single pancreatic beta-cells of different species. Anal Chem 1999; 71: 5551– 5556 10624159
  22. [25]Finnegan JM Pihel K Cahill PS Huang L Zerby SE Ewing AG Kennedy RT Wightman RM: Vesicular quantal size measured by amperometry at chromaffin, mast, pheochromocytoma, and pancreatic beta-cells. J Neurochem 1996; 66: 1914– 1923 8780018
  23. [26]Gylfe E: Association between 5-hydroxytryptamine release and insulin secretion. J Endocrinol 1978; 78: 239– 248 359742
  24. [27]Takahashi N Kadowaki T Yazaki Y Miyashita Y Kasai H: Multiple exocytotic pathways in pancreatic beta cells. J Cell Biol 1997; 138: 55– 64 9214381 PMC2139953
  25. [29]Rhee JS Ebihara S Akaike N: Gramicidin perforated patch-clamp technique reveals glycine-gated outward chloride current in dissociated nucleus solitarii neurons of the rat. J Neurophysiol 1994; 72: 1103– 1108 7528790
  26. [30]Michalik M Erecińska M: GABA in pancreatic islets: metabolism and function. Biochem Pharmacol 1992; 44: 1– 9 1632824
  27. [31]Henquin JC Dufrane D Nenquin M: Nutrient control of insulin secretion in isolated normal human islets. Diabetes 2006; 55: 3470– 3477 17130494
  28. [32]Eberhardson M Patterson S Grapengiesser E: Microfluorometric analysis of Cl- permeability and its relation to oscillatory Ca2+ signalling in glucose-stimulated pancreatic beta-cells. Cell Signal 2000; 12: 781– 786 11152964
  29. [33]Ben-Ari Y: Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 2002; 3: 728– 739 12209121
  30. [34]Best L: Glucose-induced electrical activity in rat pancreatic beta-cells: dependence on intracellular chloride concentration. J Physiol 2005; 568: 137– 144 16024506 PMC1474780
  31. [35]Dong H Kumar M Zhang Y Gyulkhandanyan A Xiang YY Ye B Perrella J Hyder A Zhang N Wheeler M Lu WY Wang Q: Gamma-aminobutyric acid up- and downregulates insulin secretion from beta cells in concert with changes in glucose concentration. Diabetologia 2006; 49: 697– 705 16447058
  32. [36]Barnett DW Pressel DM Misler S: Voltage-dependent Na+ and Ca2+ currents in human pancreatic islet beta-cells: evidence for roles in the generation of action potentials and insulin secretion. Pflugers Arch 1995; 431: 272– 282 9026789
  33. [37]Misler S Barnett DW Gillis KD Pressel DM: Electrophysiology of stimulus-secretion coupling in human beta-cells. Diabetes 1992; 41: 1221– 1228 1397696
  34. [38]Smismans A Schuit F Pipeleers D: Nutrient regulation of gamma-aminobutyric acid release from islet beta cells. Diabetologia 1997; 40: 1411– 1415 9447948
  35. [39]Semyanov A Walker MC Kullmann DM Silver RA: Tonically active GABA A receptors: modulating gain and maintaining the tone. Trends Neurosci 2004; 27: 262– 269 15111008
  36. [40]Luef G Abraham I Hoppichler F Trinka E Unterberger I Bauer G Lechleitner M: Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy. Metabolism 2002; 51: 1274– 1278 12370846

Authors
Braun, M., Ramracheya, R., Bengtsson, M., Clark, A., Walker, J. N., Johnson, P. R., & Rorsman, P.
Affiliations
  • Churchill Hospital (GB)
  • John Radcliffe Hospital (GB)
Corresponding author
Braun, Matthias
Venue
Diabetes
Published
2010-04-22
Volume
59
Issue
7
Pages
1694-1701
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2147962660
Cited by
239
References
40
Citations by year
2026: 10 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 20 · 2020: 19 · 2019: 20 · 2018: 12 · 2017: 10 · 2016: 9 · 2015: 17 · 2014: 22 · 2013: 16 · 2012: 14
FWCI
13.72
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Wellcome Trust
  • National Institute for Health and Care Research
  • European Commission (LSHB-CT-2004-005137, 005137)
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
GABA, GABAA receptor, pancreatic beta cells, autocrine signaling, human pancreatic islets, GABA release, insulin secretion, delta cells, alpha cells, GABAergic neurotransmission, SR95531, beta-cell electrical activity, action potential firing, GABAA receptor subunits
MeSH terms
Insulin Secretion, Action Potentials, Cells, Cultured, gamma-Aminobutyric Acid, Glucose, Humans, Immunohistochemistry, Insulin, Microscopy, Electron, Receptors, GABA-A, RNA, Messenger, Patch-Clamp Techniques, Paracrine Communication, Reverse Transcriptase Polymerase Chain Reaction, Insulin-Secreting Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review